Table 5.
Morbidity and mortality rates
| Study |
Complication rates |
Mortality rates |
||||
| ERP | Usual care | P value | ERP | Usual care | P value | |
| Porter et al[53] | 56 (70) | 52 (76) | 0.210 | 2 (3) | 1 (1) | 0.870 |
| Vanounou et al[54] | 77 (54) | 40 (62) | 0.207 | 2 (1) | 1 (2) | 0.918 |
| Kennedy et al[55] | 34 (37) | 19 (44) | > 0.05 | 1 (1) | 1 (2) | > 0.05 |
| Balzano et al[56] | 119 (47) | 148 (59) | 0.014 | 9 (4) | 7 (3) | 0.798 |
| Kennedy et al[57] | 11 (16) | 15 (38) | > 0.05 | 1 (1) | 1 (2) | > 0.05 |
| Nikfarjam et al[58] | NR | NR | NR | NR | - | |
| Abu Hilal et al[59] | 8 (40) | 6 (67) | 0.077 | 0 | 0 | - |
| Braga et al[60] | 69 (60) | 76 (66) | 0.339 | 4 (4) | 4 (4) | 1 |
| Kobayashi et al[61] | 39 (39) | 54 (60) | 0.004 | 0 | 1.1 | 0.957 |
| Nussbaum et al[62] | 13 (26) | 24 (24) | 0.842 | 0 | 0 | - |
| Nussbaum et al[63] | 43 (43) | 53 (41) | 0.792 | 1 (1) | 4 (3) | 0.651 |
| Coolsen et al[64] | 46 (53) | 48 (49) | > 0.05 | 4 (5) | 6 (6) | > 0.05 |
| Shao et al[65] | 127 (39) | 173 (55.8) | < 0.001 | 40 (12) | 53 (17) | NR |
| Sutcliffe et al[66] | 15 (34) | 15 (41) | 0.650 | 2 (3) | 2 (3) | 1 |
| Joliat et al[67] | 50 (68) | 71 (82) | 0.046 | 3 (4) | 4 (5) | 1 |
| Morales Soriano et al[68] | 12 (30) | 24 (55) | 0.029 | 0 | 2 (2) | > 0.05 |
| Richardson et al[69] | 6 (27) | 17 (39) | 0.421 | 0 | 0 | - |
Data are reported as number of patients (%). ERP: Enhanced recovery pathway.